MF研究者総覧

教員活動データベース

Age distribution and disease severity of COVID-19 patients continued to change in a time-dependent manner from May 2021 to April 2022 in the regional core hospital in Japan

発表形態:
原著論文
主要業績:
主要業績
単著・共著:
共著
発表年月:
2023年03月
DOI:
10.5582/ddt.2022.01111
会議属性:
指定なし
査読:
有り
リンク情報:

日本語フィールド

著者:
*Kawaura F, Kishi T, Yamamoto T, Nakayama S, Goto T, Tsurusawa R, Katagiri T, Yamanouchi K, Matsuo A, Kobayashi-Watanabe N, Imamura T, Hirooka Y, Takagi K, Umemura T, Fujimoto K, Hayashi S, Takamori A
題名:
Age distribution and disease severity of COVID-19 patients continued to change in a time-dependent manner from May 2021 to April 2022 in the regional core hospital in Japan
発表情報:
Drug Discov Ther 巻: 17 号: 1 ページ: 60-65
キーワード:
SARS-CoV-2; coronavirus disease 2019; infectivity; mortality; severe acute respiratory syndrome coronavirus 2
概要:
The present retrospective study aimed to examine the real-world data regarding time-dependent changes in the age distribution of patients with coronavirus disease 2019 (COVID-19) as well as the severity and infectivity in a regional core hospital in Japan. Patients with COVID-19 who visited the fever outpatient branch in Takagi Hospital during phase I (May 1 to December 31, 2021), and during phase II (January 1 to April 30, 2022) were evaluated. The age distribution of outpatients and the characteristics of inpatients aged > 75 years were compared between phases I and II. The age distribution of outpatients shifted from the older generation in phase I to the younger generation in phase II (p < 0.01). Disease severity might be reduced in a time-dependent manner with a decrease in the hospitalization rate (phase I: 145/368 (39.4%); phase II: 104/1496 (7.0%); p < 0.01) and mortality rate (phase I: 10/368 (2.7%); phase II: 7/1496 (0.5%); p < 0.01). The number of patients increased in phase II (374.0/month) compared to that in phase I (36.8/month). Regarding the older inpatients, the disease severity of COVID-19 and hospitalization days were reduced in phase II compared to those in phase I (p < 0.01, each). In conclusion, the present study suggests a change in the age distribution of patients with COVID-19, a decrease in toxicity, and an increase in infectivity of severe acute respiratory syndrome coronavirus 2 in a time-dependent manner.
抄録:

英語フィールド

Author:
*Kawaura F, Kishi T, Yamamoto T, Nakayama S, Goto T, Tsurusawa R, Katagiri T, Yamanouchi K, Matsuo A, Kobayashi-Watanabe N, Imamura T, Hirooka Y, Takagi K, Umemura T, Fujimoto K, Hayashi S, Takamori A
Title:
Age distribution and disease severity of COVID-19 patients continued to change in a time-dependent manner from May 2021 to April 2022 in the regional core hospital in Japan
Announcement information:
Drug Discov Ther Vol: 17 Issue: 1 Page: 60-65
Keyword:
SARS-CoV-2; coronavirus disease 2019; infectivity; mortality; severe acute respiratory syndrome coronavirus 2
An abstract:
The present retrospective study aimed to examine the real-world data regarding time-dependent changes in the age distribution of patients with coronavirus disease 2019 (COVID-19) as well as the severity and infectivity in a regional core hospital in Japan. Patients with COVID-19 who visited the fever outpatient branch in Takagi Hospital during phase I (May 1 to December 31, 2021), and during phase II (January 1 to April 30, 2022) were evaluated. The age distribution of outpatients and the characteristics of inpatients aged > 75 years were compared between phases I and II. The age distribution of outpatients shifted from the older generation in phase I to the younger generation in phase II (p < 0.01). Disease severity might be reduced in a time-dependent manner with a decrease in the hospitalization rate (phase I: 145/368 (39.4%); phase II: 104/1496 (7.0%); p < 0.01) and mortality rate (phase I: 10/368 (2.7%); phase II: 7/1496 (0.5%); p < 0.01). The number of patients increased in phase II (374.0/month) compared to that in phase I (36.8/month). Regarding the older inpatients, the disease severity of COVID-19 and hospitalization days were reduced in phase II compared to those in phase I (p < 0.01, each). In conclusion, the present study suggests a change in the age distribution of patients with COVID-19, a decrease in toxicity, and an increase in infectivity of severe acute respiratory syndrome coronavirus 2 in a time-dependent manner.


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.